Is Neonatal Viremia a Possible Predictor of the Timing of Maternal Infection in Asymptomatic Congenital Cytomegalovirus Infection? A Retrospective Study
<b>Background:</b> Asymptomatic congenital cytomegalovirus (acCMV) infections represent 85-90% of all congenital CMV infection. The incidence of late-onset sequelae in these cases significantly contribute to the burden of CMV disease. The timing of maternal infection (TMI) has been identified as the main predictor of late-onset sequelae in acCMV infants, and follow-up programs in Europe are currently calibrated according to the TMI. Our aim was to evaluate neonatal viremia as a possible predictor of the TMI in acCMV infections. <b>Methods:</b> Plasma viral loads (PVLs) were assessed in the first month of life in a population of acCMV-infected newborns delivered by women who suffer a primary CMV infection during pregnancy. TMI was assigned to a trimester of pregnancy according to the maternal serological screening. PVLs were evaluated in relation to the TMI and gestational age (GA) at birth. <b>Results:</b> One hundred and ten newborns were, respectively, assigned to preconceptional (6.4%), 1st (27.3%), 2nd (38.2%), and 3rd (28.2%) trimester infections. Median neonatal PVLs values were significantly different between groups (<i>p</i> < 0.001). First-trimester infections exhibited significantly higher PVLs when compared with third-trimester ones (<i>p</i> < 0.001). Overall, PVLs showed an inverse correlation with GA at birth (<i>p</i> = 0.003). <b>Conclusions:</b> Median neonatal PVLs are significantly higher in 1st trimester infections if compared with 3rd trimester ones, but a wide overlap between PVL values prevent their possible use as a predictor of the TMI. In our population, a significant inverse relationship, mainly dependent on 1st and 2nd trimester infections, is demonstrated between PVLs and GA. Overall, fetal viremia is already decreasing weeks before the term of pregnancy.
Authors
- Ombretta Turriziani (ORCID: https://orcid.org/0000-0001-6400-9168)
- Barbara Caravale (ORCID: https://orcid.org/0000-0002-6761-6075)
- Rosaria Turchetta
- Giuseppina Liuzzi (ORCID: https://orcid.org/0000-0003-0287-0010)
- Gianluca Terrin (ORCID: https://orcid.org/0000-0003-3541-2876)
- Giuseppe Maria Albanese (ORCID: https://orcid.org/0000-0001-7562-9274)
- Francesco Franco (ORCID: https://orcid.org/0000-0002-9869-2820)
- Giovanni Boscarino (ORCID: https://orcid.org/0000-0003-2481-0692)
- Raffaella Cellitti
- Fabrizia Bonci
- Maria Giulia Conti (ORCID: https://orcid.org/0000-0001-8659-4652)
- Fabio Natale (ORCID: https://orcid.org/0000-0002-2513-9899)
- Antonella Giancotti (ORCID: https://orcid.org/0000-0002-0427-5613)
Institutions
- Policlinico Umberto I (IT)
- Istituto Nazionale per le Malattie Infettive Lazzaro Spallanzani (IT)
- Agenzia Regionale Parchi (IT)
- St. Eugenio Hospital (IT)
- Istituti di Ricovero e Cura a Carattere Scientifico (IT)
- Sapienza University of Rome (IT)
Publication Details
- Journal
- Journal of Personalized Medicine
- Published
- 2025-04-24
- DOI
- https://doi.org/10.3390/jpm15050165
- Primary Topic
- Cytomegalovirus and herpesvirus research
- Type
- article
- Field-Weighted Citation Impact
- 0.00